Literature DB >> 594913

Non-confirmation of thalidomide induced teratogenesis in rats and mice.

W J Scott, R Fradkin, J G Wilson.   

Abstract

It has been reported that thalidomide, dissolved in a 1:3 mixture of Tween 20 and physiological saline and administered intraperitoneally to pregnant mice and rats induces a variety of malformations, including limb deformaties, characteristic of the primate syndrome. The studies reported herein attempted to confirm these findings without success although the rodent strains used were not the same. A low level of non-specific malformations was observed in the fetuses of both species at dose levels reported to cause a 47 percent and 92 percent rate of malformation in mice and rats respectively. One possible source of difference was Tween 20 which was toxic to the point of lethality in these studies at dose levels reported to be non-toxic in the earlier studies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 594913     DOI: 10.1002/tera.1420160313

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  5 in total

1.  Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals.

Authors:  H Sauer; J Günther; J Hescheler; M Wartenberg
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Drug chirality and its clinical significance.

Authors:  A J Hutt; S C Tan
Journal:  Drugs       Date:  1996       Impact factor: 9.546

3.  Embryotoxic effects of thalidomide derivatives on the non-human primate Callithrix jacchus; 3. Teratogenic potency of the EM 12 enantiomers.

Authors:  W Heger; S Klug; H J Schmahl; H Nau; H J Merker; D Neubert
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

4.  Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood.

Authors:  R Neubert; A C Nogueira; D Neubert
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

5.  The enantiomers of the teratogenic thalidomide analogue EM 12: 1. Chiral inversion and plasma pharmacokinetics in the marmoset monkey.

Authors:  H J Schmahl; H Nau; D Neubert
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.